ChIP-on-Chip Analysis of In Vivo Mutant p53 Binding To Selected Gene Promoters
- 1 May 2011
- journal article
- research article
- Published by Mary Ann Liebert Inc in OMICS: A Journal of Integrative Biology
- Vol. 15 (5), 305-312
- https://doi.org/10.1089/omi.2010.0084
Abstract
Growing evidence shows that mutant p53 proteins, which are present in many human tumors, gain oncogenic activities that can actively contribute to tumorigenesis. Mutant p53 proteins have been extensively shown to affect the expression of several genes involved in various aspects of cancer biology. We show here the ChIP-on-chip analysis of mutant p53 binding to a set of 154 promoters, composed of both validated and putative mutant p53 target genes. By using the chromatin obtained from mutant p53R175H-immunoprecipitation in proliferating SKBr3 breast cancer cells, we found that mutant p53 binds to 40 of the 154 promoters analyzed. siRNA-mediated mutant p53 knock-down modulates the transcript abundance of some of these target genes. Two-thirds of the mutant p53-bound promoters were also engaged by either p300 or PCAF acetyl-transferases, strongly indicating the presence of transcriptionally active complexes. We also found that NF-kB binding sites are overrepresented among the mutant p53-bound promoters; a ChIP-on-chip analysis confirmed that NF-kB p65 binds to 27 of the mutant p53-bound promoters, indicating that mutant p53 could influence the transcriptional output of these NF-kB target genes.Keywords
This publication has 17 references indexed in Scilit:
- Mutant p53 Gain-of-Function in CancerCold Spring Harbor Perspectives in Biology, 2009
- The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesisNature Structural & Molecular Biology, 2009
- When mutants gain new powers: news from the mutant p53 fieldNature Reviews Cancer, 2009
- TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancerBreast Cancer Research, 2007
- Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulationCancer Cell, 2006
- High-Throughput Screening of Chromatin Immunoprecipitates Using CpG-Island MicroarraysMethods in Enzymology, 2003
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- The Transcriptional Repressor ZEB Regulates p73 Expression at the Crossroad between Proliferation and DifferentiationMolecular and Cellular Biology, 2001
- p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer DrugsThe Journal of Experimental Medicine, 1998
- Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 ExpressionMolecular and Cellular Biology, 1995